ENDRA Life Sciences : (Former name or former address, if changed since last report) (Form 8-K)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock, par value $0.0001 per share	NDRA	The Nasdaq Stock Market LLC
Warrants, each to purchase one share of Common Stock	NDRAW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☑

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07. Submission of Matters to a Vote of Security Holders.

The Company held its 2021 Annual Meeting of Stockholders (the 'Annual Meeting') on June 8, 2021. The certified results of the matters voted upon at the meeting, which are more fully described in the Proxy Statement for the 2021 Annual Meeting of Stockholders of the Company as filed with the Securities and Exchange Commission on April 29, 2021, are as follows:

Proposal 1 - The Company's stockholders elected the five directors nominated by the Company's Board of Directors to serve until the next annual meeting of stockholders and the election of their successors:

	For		Withheld
Francois Michelon	10,650,147		104,871
Louis J. Basenese	10,664,554		90,464
Anthony DiGiandomenico	10,200,479		554,539
Michael Harsh	10,222,660		532,358
Alexander Tokman	10,257,616		497,402

Proposal 2 - The Company's stockholders ratified the appointment of RBSM LLP by the Audit Committee of the Board of Directors as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2021:

For		Against		Abstain
21,627,326		2,557		25,377

There were no broker non-votes on these proposals.